Saluda Medical Revenue and Competitors
Estimated Revenue & Valuation
- Saluda Medical's estimated annual revenue is currently $204.2M per year.
- Saluda Medical's estimated revenue per employee is $351,400
- Saluda Medical's total funding is $638M.
Employee Data
- Saluda Medical has 581 Employees.
- Saluda Medical grew their employee count by 9% last year.
Saluda Medical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Chief People Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | CTO | Reveal Email/Phone |
5 | VP, Regulatory Affairs | Reveal Email/Phone |
6 | Head European Sales | Reveal Email/Phone |
7 | VP Scientific Affairs | Reveal Email/Phone |
8 | Head Sales Enablement + Senior Sales Director | Reveal Email/Phone |
9 | VP Strategic Marketing | Reveal Email/Phone |
10 | SVP, Regulatory Affairs and Quality Assurance | Reveal Email/Phone |
Saluda Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $204.2M | 581 | 9% | $638M | N/A |
#2 | $41.4M | 165 | -2% | N/A | N/A |
#3 | $6.5M | 52 | -24% | $20.8M | N/A |
#4 | $17.6M | 70 | 11% | N/A | N/A |
#5 | $50.8M | 162 | -13% | $5M | N/A |
#6 | $23.6M | 94 | 8% | N/A | N/A |
#7 | $27.9M | 111 | -2% | N/A | N/A |
#8 | $272.3M | 1085 | 6% | N/A | N/A |
#9 | $27.6M | 110 | -2% | N/A | N/A |
#10 | $42.2M | 168 | 17% | N/A | N/A |
What Is Saluda Medical?
Saluda Medical is a start-up medical device company. Saluda Medical develops advanced fully implantable neuromodulation systems for the next generation of implantable stimulation devices. We are a cutting edge, progressive, 100% Australian company at the forefront of spinal cord stimulation technologies for the management of chronic pain
keywords:N/A
$638M
Total Funding
581
Number of Employees
$204.2M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Saluda Medical News
2) The $125m private equity of Saluda Medical by Fidelity Management & Research,Redmile Group and T Rowe Price Associates.
Saluda Medical, which is developing a spinal neuromodulation system, landed $125 million in equity financing at the beginning of March.
Saluda Medical has finalised US$125 million in equity financing, with the proceeds being used in part to operationalise and scale...
NEW YORK, July 6, 2021 /PRNewswire-PRWeb/ -- Saluda Grade (SG) has completed a transformative capital raise of $100 million through a first-ever Collateralized Asset Financing (CAF) securitization. The private placement was structured and placed by Jefferies, with an oversubscription of demand f ...
ARTARMON, Australia, Feb. 12, 2021 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the treatment of chronic pain, today announced the appointment of Jim Schuermann as President & Chief Ex ...
Other Companies in Artarmon
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $473.4M | 1166 | -1% | N/A |
#2 | $510.3M | 1778 | 1% | N/A |